Savara, Inc. (SVRA)
4.72
-0.27
(-5.41%)
USD |
NASDAQ |
Nov 12, 16:00
4.73
+0.01
(+0.21%)
After-Hours: 07:24
Savara Shareholders Equity (Quarterly) : 107.85M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 107.85M |
| June 30, 2026 | 143.66M |
| March 31, 2026 | 176.04M |
| December 31, 2025 | 203.13M |
| September 30, 2025 | 94.39M |
| June 30, 2025 | 120.48M |
| March 31, 2025 | 147.85M |
| December 31, 2024 | 171.45M |
| September 30, 2024 | 199.35M |
| June 30, 2024 | 101.73M |
| March 31, 2024 | 121.86M |
| December 31, 2023 | 140.37M |
| September 30, 2023 | 146.54M |
| June 30, 2023 | 87.72M |
| March 31, 2023 | 98.26M |
| December 31, 2022 | 107.78M |
| September 30, 2022 | 116.51M |
| June 30, 2022 | 127.04M |
| March 31, 2022 | 136.48M |
| December 31, 2021 | 144.50M |
| September 30, 2021 | 155.23M |
| June 30, 2021 | 165.38M |
| March 31, 2021 | 175.12M |
| December 31, 2020 | 64.38M |
| September 30, 2020 | 76.63M |
| Date | Value |
|---|---|
| June 30, 2020 | 83.80M |
| March 31, 2020 | 87.32M |
| December 31, 2019 | 101.70M |
| September 30, 2019 | 106.80M |
| June 30, 2019 | 112.80M |
| March 31, 2019 | 101.80M |
| December 31, 2018 | 108.22M |
| September 30, 2018 | 117.85M |
| June 30, 2018 | 82.71M |
| March 31, 2018 | 93.70M |
| December 31, 2017 | 119.31M |
| September 30, 2017 | 74.64M |
| June 30, 2017 | 79.77M |
| March 31, 2017 | 4.35M |
| December 31, 2016 | 7.986M |
| September 30, 2016 | 13.19M |
| June 30, 2016 | 16.43M |
| March 31, 2016 | 20.68M |
| December 31, 2015 | 23.89M |
| September 30, 2015 | 33.54M |
| June 30, 2015 | 42.54M |
| March 31, 2015 | 50.11M |
| December 31, 2014 | 58.66M |
| September 30, 2014 | 45.25M |
| June 30, 2014 | 50.22M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Vericel Corp. | 384.17M |
| Biogen, Inc. | 18.92B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 155.93M |
| Total Liabilities (Quarterly) | 48.08M |
| Debt to Equity Ratio | 0.2815 |
| Current Ratio | 8.546 |
| Net Debt Paydown Yield | -0.01% |